Seeing Is Believing
Currently out of the existing stock ratings of Yi Chen, 410 are a BUY (90.11%), 43 are a HOLD (9.45%), 2 are a SELL (0.44%).
Analyst Yi Chen, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 35.3% that have a potential upside of 51.74% achieved within 158 days.
Yi Chen’s has documented 848 price targets and ratings displayed on 43 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ICCM, Icecure Medical at 28-Mar-2025.
Analyst best performing recommendations are on CELC (CELCUITY LLC).
The best stock recommendation documented was for KPRX (KIORA PHARMACEUTICALS) at 7/11/2022. The price target of $100 was fulfilled within 3 days with a profit of $60.56 (37.72%) receiving and performance score of 125.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
10 months 27 days ago
(03-May-2024)
2/5 (40%)
$13.4 (372.22%)
248
Buy
$15
1 years 17 days ago
(13-Mar-2024)
1/9 (11.11%)
$11.06 (280.71%)
11
Which stock is Yi Chen is most bullish on?
Which stock is Yi Chen is most reserved on?
What Year was the first public recommendation made by Yi Chen?